Cargando…

Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer’s disease pathology in Down syndrome

Amyloid beta (Aβ) is thought to play a critical role in the pathogenesis of Alzheimer’s disease (AD). Prion-like Aβ polymorphs, or “strains”, can have varying pathogenicity and may underlie the phenotypic heterogeneity of the disease. In order to develop effective AD therapies, it is critical to ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maxwell, Alison M., Yuan, Peng, Rivera, Brianna M., Schaaf, Wilder, Mladinov, Mihovil, Prasher, Vee P., Robinson, Andrew C., DeGrado, William F., Condello, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711167/ https://www.ncbi.nlm.nih.gov/pubmed/34961556 http://dx.doi.org/10.1186/s40478-021-01298-0

Ejemplares similares

The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome
por: Davidson, Yvonne S., et al.
Publicado: (2018)

Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome
por: Prasher, Vee P, et al.
Publicado: (2016)

Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer’s Disease Associated with Down Syndrome
por: Ichimata, Shojiro, et al.
Publicado: (2023)

Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s disease
por: Mann, David M. A., et al.
Publicado: (2018)

EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains
por: Yang, Hyunjun, et al.
Publicado: (2023)

EMBER multi-dimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains
por: Yang, Hyunjun, et al.
Publicado: (2023)

Genetic variants conferring susceptibility to Alzheimer’s disease in the general population; do they also predispose to dementia in Down’s syndrome
por: Patel, Ashok, et al.
Publicado: (2014)

Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer’s disease
por: Condello, Carlo, et al.
Publicado: (2018)

Blood Beta-Amyloid and Tau in Down Syndrome: A Comparison with Alzheimer’s Disease
por: Lee, Ni-Chung, et al.
Publicado: (2017)

An Intron 7 Polymorphism in APP Affects the Age of Onset of Dementia in Down Syndrome
por: Jones, Emma L., et al.
Publicado: (2010)

Short peptides self-assemble to produce catalytic amyloids
por: Rufo, Caroline M., et al.
Publicado: (2014)

Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer's disease
por: Liu, He, et al.
Publicado: (2021)

Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta
por: Lopez Sanchez, M. Isabel G., et al.
Publicado: (2017)

[(18)F]Tetrafluoroborate ([(18)F]TFB) and its analogs for PET imaging of the sodium/iodide symporter
por: Jiang, Huailei, et al.
Publicado: (2018)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

Amyloid Beta Peptide Slows Down Sensory-Induced Hippocampal Oscillations
por: Peña-Ortega, Fernando, et al.
Publicado: (2012)

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores
por: Arbor, Sage C., et al.
Publicado: (2016)

Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
por: Pandey, Mukesh K., et al.
Publicado: (2016)

Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects
por: Pandey, Mukesh K., et al.
Publicado: (2021)

Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022)

A Real-Time All-Atom Structural Search Engine for Proteins
por: Gonzalez, Gabriel, et al.
Publicado: (2014)

Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline
por: Cole, James H., et al.
Publicado: (2017)

Editorial on, “Amyloid-beta clearance in Alzheimer's disease”
por: Marr, Robert A.
Publicado: (2014)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
por: Amakiri, Nnana, et al.
Publicado: (2019)

Amyloid-beta immunotherapy: the hope for Alzheimer disease?
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)

An Assay Suitable for High Throughput Screening of Anti-Influenza Drugs
por: Mao, Lili, et al.
Publicado: (2013)

Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics
por: Watkins, Laura C., et al.
Publicado: (2020)

Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell
por: Hu, Yanmei, et al.
Publicado: (2022)

An amyloid beta vaccine that safely drives immunity to a key pathological species in Alzheimer’s disease: pyroglutamate amyloid beta
por: Vukicevic, M., et al.
Publicado: (2022)

Distinct effects of beta‐amyloid and tau on cortical thickness in cognitively healthy older adults
por: Harrison, Theresa M., et al.
Publicado: (2020)

The amyloid beta ion channel hypothesis of Alzheimer’s disease
por: Shirwany, Najeeb A, et al.
Publicado: (2007)

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
por: Cheignon, C., et al.
Publicado: (2017)

Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018)

Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
por: Wildburger, Norelle C., et al.
Publicado: (2017)

Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
por: Sadigh-Eteghad, Saeed, et al.
Publicado: (2015)

The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer’s Disease
por: Hillen, Heinz
Publicado: (2019)

Natural Products Targeting Amyloid Beta in Alzheimer’s Disease
por: Lee, Joo-Hee, et al.
Publicado: (2021)

Optical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
por: Luo, Ziyi, et al.
Publicado: (2021)

Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology
por: Hefner, Marleigh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n1ct6dqfnv4oaljo0l6rvsfsfa